A photo of Yael Haberman Ziv.

Yael Haberman Ziv, MD, PhD


  • Adjunct Assistant Professor, UC Department of Pediatrics

About

PhD: Tel-Aviv University, Tel-Aviv, Israel, 2006.

MD: Tel-Aviv University, Tel-Aviv, Israel, 2007.

Residency: Pediatrics, Sheba Medical Center, Tel -Hashomer, Israel, 2011.

Fellowship: Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014.

Services and Specialties

Gastroenterology GI, Autoimmune Liver Disease

Research Areas

Gastroenterology Hepatology and Nutrition

Publications

Lack of gut microbiome recovery with spinal cord injury rehabilitation. Gur Arie, A; Toren, T; Hadar, R; Braun, T; Efroni, G; Glick Saar, E; Madar, Z; Amir, A; Zeilig, G; Haberman, Y. Gut Microbes. 2024; 16:2309682.

Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort. Braun, T; Feng, R; Amir, A; Levhar, N; Shacham, H; Mao, R; Hadar, R; Toren, I; Algavi, Y; Abu-Saad, K; Elinav, E; Chen, M; Ben-Horin, S; Haberman, Y. Nature Communications. 2024; 15:3764.

Lubricating gel influence on vaginal microbiome sampling. Amitai Komem, D; Hadar, R; Paulson, JN; Mordechai, Y; Eskandarian, HA; Efroni, G; Amir, A; Haberman, Y; Tsur, A. Scientific Reports. 2024; 14:18223.

Housing RCS rats under specific pathogen-free conditions mildly ameliorates retinal degeneration and alters intestine microbiota. Ketter-Katz, H; Saeed, R; Sher, I; Altmann, G; Shadi, T; Dallasheh, S; Lustig-Barzelay, Y; Sabo, A; Jejelava, G; Hadar, R; Efroni, G; Amir, A; Braun, T; Haberman, Y; Rotenstreich, Y. Scientific Reports. 2024; 14:21583.

STARD7 maintains intestinal epithelial mitochondria architecture, barrier integrity, and protection from colitis. Uddin, J; Sharma, A; Wu, D; Tomar, S; Ganesan, V; Reichel, PE; Thota, LN R; Cabrera-Silva, RI; Marella, S; Idelman, G; Divanovic, S; Nusrat, A; Weaver, TE; Hogan, SP. JCI insight. 2024; 9:e172978.

Editorial: Distinct Challenges of Paediatric From Adult-Onset Inflammatory Bowel Disease, Implications of Aggressive Disease Phenotypes and Early Biologic Therapy in Children-Authors' Reply. Granot, M; Weiss, B; Haberman, Y. Alimentary Pharmacology and Therapeutics. 2024; 60:1473-1474.

Differences in disease characteristics and treatment exposures between paediatric and adult-onset inflammatory bowel disease using a registry-based cohort. Granot, M; Kopylov, U; Loberman-Nachum, N; Krauthammer, A; Abitbol, CM; Ben-Horin, S; Weiss, B; Haberman, Y. Alimentary Pharmacology and Therapeutics. 2024; 60:1435-1446.

Long-term metabolic effects of non-nutritive sweeteners. Rathaus, M; Azem, L; Livne, R; Ron, S; Ron, I; Hadar, R; Efroni, G; Amir, A; Braun, T; Haberman, Y; Tirosh, A. Molecular Metabolism. 2024; 88:101985.

The efficacy of curcumin/Qing Dai combination in children with active ulcerative colitis: a multicenter retrospective cohort study. Nachum, NL; Salomon, N; Yerushalmy-Feler, A; Weintraub, Y; Yogev, D; Granot, M; Haberman, Y; Ben-Horin, S; Weiss, B. Frontiers in Pediatrics. 2024; 12:1342656.

Duodenal transcriptomics demonstrates signatures of tissue inflammation and immune cell infiltration in children with environmental enteric dysfunction across global centers. Marie, C; Das, S; Coomes, D; Ahmed, T; Ali, SA; Iqbal, J; Kelly, P; Mahfuz, M; Moore, SR; Petri, WA; Tarr, PI; Denson, LA. American Journal of Clinical Nutrition. 2024; 120 Suppl 1:S51-S64.